CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,841,175 | +47.3% | 157,500 | +69.4% | 0.35% | +52.6% |
| Q2 2023 | $1,249,920 | -18.9% | 93,000 | 0.0% | 0.23% | -5.0% |
| Q1 2023 | $1,541,940 | +33.7% | 93,000 | +50.0% | 0.24% | +28.7% |
| Q4 2022 | $1,153,200 | +45.1% | 62,000 | 0.0% | 0.19% | +37.2% |
| Q3 2022 | $795,000 | -12.7% | 62,000 | -52.3% | 0.14% | -12.7% |
| Q2 2022 | $911,000 | +61.5% | 130,000 | +91.2% | 0.16% | +42.7% |
| Q1 2022 | $564,000 | +22.6% | 68,000 | 0.0% | 0.11% | +8.9% |
| Q4 2021 | $460,000 | -30.0% | 68,000 | -45.2% | 0.10% | -30.3% |
| Q3 2021 | $657,000 | -7.9% | 124,000 | 0.0% | 0.14% | -2.0% |
| Q2 2021 | $713,000 | – | 124,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |